Related Experiment Video
Updated: Oct 4, 2025

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Data Sources for Drug Utilization Research in Brazil-DUR-BRA Study.
Lisiane Freitas Leal1, Claudia Garcia Serpa Osorio-de-Castro2, Luiz Júpiter Carneiro de Souza3
1Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.
This study identified and characterized 38 Brazilian healthcare data sources for drug utilization research. While many are publicly accessible, a lack of uniform drug coding and data quality evaluation hinders pharmacoepidemiologic research.
Area of Science:
- Health Informatics
- Pharmacoepidemiology
- Health Services Research
Background:
- Pharmacoepidemiologic research in Brazil lacks comprehensive mapping of electronic healthcare databases.
- Existing studies have not sufficiently assessed the suitability of these databases for drug utilization research.
Purpose of the Study:
- To identify, catalogue, and characterize Brazilian data sources relevant for Drug Utilization Research (DUR).
- To assess the suitability of these data sources for pharmacoepidemiologic studies.
Main Methods:
- A network of Brazilian health experts was assembled to map secondary administrative healthcare data.
- A multi-phase approach including internet searches, bibliographic databases, and expert input was employed.
- Data sources were categorized (automated databases, EMRs, surveys, adverse event systems, others) and characterized by accessibility, granularity, setting, data type, and coverage.
Main Results:
- 38 out of 62 identified data sources met eligibility criteria and were characterized.
- Automated databases comprised the largest category (60%), followed by adverse event reporting systems and EMRs (11% each).
- 47% were publicly accessible online, offering national-level data, often with over 5 years of coverage at individual and aggregated levels; however, drug coding was non-uniform, and population coverage details were absent.
Conclusions:
- Brazil possesses diverse data sources for Drug Utilization Research.
- A significant limitation is the absence of a uniform drug classification system and standardized data quality evaluation.
- Further characterization of these data sources is needed to optimize their use in pharmacoepidemiologic research.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Methods for Studying Drug Absorption: In situ
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
Analysis of Population Pharmacokinetic Data
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
Therapeutic Drug Monitoring: Drug Analysis Methods
Drug Distribution: Volume of Distribution

